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Catalog of Teratogenic Agents (3rd Edn).
T. H. SHEPARD (1980). London: Johns
Hopkins Univ. Press. 410 pp. £15-75.
As in previous editions, theinformation has
been obtained using a computer programme,
and the print-out has not been type-set. The
author points out the savings in cost, but the
presentation is unattractive, and it is for-
tunate that the book is a reference source for
specific items and need not be read as a
whole.
This latest edition contains an additional
600 items, with a thorough coverage of the
Japanese and Russian literature. There are
both subject and author indices and the
material is not restricted to specific chemicals
but, for example, includes references to the
effects of vaccines, viruses and dietary
deficiencies. Inside the front and back covers
there is also a useful table comparing the
timing of embryonic and foetal development
in man and experimental animals. Overall,
the book can be recommended as an ex-
tremely useful source of information on
teratogenic agents.
A. W. CRAIG
Tumor Antigenicity and Approaches to
Tumor Immunotherapy. D. W. WEISS
(1980). Berlin, Heidelberg, New York:
Springer-Verlag. 83 pp. $17-20.
The prospects of immunotherapy for
clinical cancer have been kept bright for
almost a century, not by the glow ofgathering
success but by the floodlight of promotion,
iteration, promise and pretence that the
seductive notion has inclined us to indulge.
Now that the interim results of many
hundreds of clinical trials are emerging, it is
seen that the impressive vessel of ideas has,
very largely, foundered in the cancer wards.
To the disappointment of many clinical
oncologists, who have acted on recom-
mendations from laboratory-animal data of
questionable clinical relevance, has been
added a streak of indignation; even tumour
immunologists are confessing to low spirits.
The fortunes of applied tumour immunology
are evidently on a depression oftheir familiar
undulation. Morale has to be restored, the
image of novelty and excitement retouched,
support retained, and a basis for rededication
supplied. Professor Weiss here provides a
strategy for redeployment.
The opening sentence of the text proclaims
the dilemma: "The central hypothesis under-
lying all attempts at immunological inter-
vention in neoplastic disease is today in
danger of falling". The quotation from
Nachman of Bratzlav which introduces the
work ("It is forbidden to despair") betrays a
mood which had been better not generated
by precocious application of inflated theory.
In the last 20 years or so the scope for
theoretical immunotherapy has been in-
creasingly widened by striking advances in
general immunology. The author, fitted by
long experience and remarkable erudition in
the field, by a facility for scrupulously
phrased expression, and by a brilliance of
optimistic imagination, has fashioned from
these advances a phantasmagoria of possible
clinical applications. The hazards and limita-
tions ofthe more daring manoeuvres, such as
the regional perfusion of allogeneic lympho-
cytes, grown up and sensitized to theoretical
TSA (or TAA) in vitro, are frankly faced, only
to be given a perhaps too confident promise
of control. Enhancement, once treated as a
hazard of immunotherapy, is recruited as an
advantage to combined therapy: "neoplastic
cells stimulated to proliferation can become
more susceptible targets for concordant
cytotoxic treatments".
Many visions familiar in the history of the
topic are re-projected with a polish from the
modern context and the author's style:
cytotoxic agents being made to "home in" to
a tumour on the backs of (now) monoclonal
antibodies; the concept of cancer as a
"neoplastic parasite"; prophylactic "vaccina-
tion" against some cancers; future discovery
of oncogenic viruses in man; the bugbear of
"escape" from "potential immune surveil-
lance"; and the spectre of "idiosyncratic host
immune failure".
If the intensity of optimism and the zeal of
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kind of incredulity in the reader, he can be
sure that Professor Weiss has anticipated
every objection and pre-empted any ground
for complaint. It is he who acknowledges that
the matrix of his text is formed of "may",
"could", "might", etc. But the disarming
recital of conditionals and the mollifying play
of doubt against confidence, of caution
against boldness, should not be allowed to
conceal some less explicit incongruities.
Whilst admitting the impertinence of the
unrealistic animal-model tumours which have
been used to formulate clinical prescriptions,
the author draws indiscriminately on infor-
mation obtained from them, as given in many
of the 460 references supporting his 62 pages
oftext.
What Professor Weiss intended he has
done only too well; in the wake ofwidespread
clinical disillusionment with theoretical
tumour immunotherapy, he has reassured the
committed that they can still be in business-
big business. But this may not be the best
"psychological" moment to outline fresh
projects; the crucial specific immunogen
remains elusive!
H. B. HEWITT
Pathology of Soft Tissue Tumours. S. L.
HAJDU (1980). London: Henry Kimpton.
599 pp. £4000.
Soft-tissue tumours have been neglected
by surgeons and pathologists. The outlook
for patients with soft-tissue sarcoma has
been bleak, with mutilating surgery the only
available remedy, and all too often an un-
availing one. The multiplicity of tumour
types, together with the rarity of each type,
has discouraged pathological endeavour in
this field. There has been until now no avail-
able book on the pathology of soft-tissue
tumours, while the advent ofeffective chemo-
therapy has emphasized the need for accurate
diagnosis and agreed classification in this
difficult area. Dr Hajdu's book, based on his
great experience at the Memorial Sloan-
Kettering Cancer Center in New York, will
therefore raise considerable expectations.
The book opens with an extended (and
largely irrelevant) historical introduction,
and there follow 9 chapters on the various
soft-tissue tumours grouped by histogenesis.
These provide a wealth of information, with
excellent black and white photomicrographs,
together with clinical photographs, radio-
graphs, electron micrographs, etc. (The colour
photomicrographs add nothing, except to the
price of the book). Many pathologists will
disagree with the very wide definition of the
fibrous histiocytoma group, and all readers
will be exasperated by the practice ofarrang-
ing the references in chronological order. The
presentation and cover design is somewhat
gimmicky, and unworthy of a serious scien-
tific work. But clinicians and pathologists
concerned with this important group of
tumours will certainly want to have this book
available.
0. G. DODGE
Radiation Biology in Cancer Research.
Ed. R. E. MEYS and H. R. WITHERS (1980).
New York: Raven Press. 681 pp. $77-52.
This volume contains the proceedings ofthe
32nd Annual Symposium on Fundamental
Cancer Research held at M.D. Anderson
Hospital and Tumor Center, Houston in
March 1979. The particular topic had last
been covered in 1964, and I still refer to that
volume when I can get hold of a copy. The
new volume is also a glossy hard-backed book
which has been published only a year after
the Conference, withoutthebenefit ofcamera-
ready manuscripts. Perhaps this explains the
high cost, but the high quality of the review
articles represents value for money which is
not always found in conference proceedings.
There is something of value for most radio-
biologists, starting with a keynote address on
survival-curve models by Tikvah Alper and
continuing with 12 articles on mechanisms of
radiation injury including the Ernst W.
Bertner Memorial Award lecture by Mortimer
Elkind on Cells, Targets and Molecules in
Radiation Biology.
A section on low doses and low dose rates
includes papers in the field of radiation
carcinogenesis. W. K. Russell concludes that
"in nearly every example the tumorigenic
effectiveness per rad of low-LET radiation
tends to decrease with decreasing dose rate.
For some tumor types the differences may be
small or may appear only with very low dose
rates, while for others the dose-rate effects
may be large".
Tumour radiobiology is discussed both
directlv in terms ofthe radiation response ofa